Mass spectrometry-based protein analysis to unravel the tissue pathophysiology in Duchenne muscular dystrophy

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Duchenne muscular dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration due to dystrophin deficiency.
• Tissue-specific variations in DMD pathophysiology present challenges for understanding disease mechanisms and developing treatments.

Purpose of the Study:

• To identify commonly altered proteins in DMD across different tissues and biological samples using proteomic data integration.
• To uncover potential therapeutic targets and biomarkers for DMD by analyzing proteome-wide changes.

Main Methods:

• A meta-analysis of published gel-free proteomic studies on dystrophin-deficient models and DMD patients.
• Creation of a database of significantly differentially expressed proteins.
• Intersection analysis of proteomic data from various tissues, blood, and urine samples.

Main Results:

• Identification of 31 commonly affected proteins across different tissues in dystrophin deficiency, implicating actin cytoskeleton maintenance and energy metabolism pathways.
• Discovery of 33 commonly differentially expressed proteins in blood and urine of DMD patients and models.
• Highlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) variability, suggesting it as an unreliable loading control.

Conclusions:

• The identified protein sets offer insights into DMD pathophysiology and suggest novel therapeutic strategies.
• Commonly altered proteins in blood and urine may serve as valuable biomarkers for monitoring DMD progression.
• The study underscores the need for alternative loading controls in proteomic assays for DMD research.